Skip to content

Article: Nicotinamide Riboside Improves Mitochondrial Health in Werner Syndrome: Preclinical Findings

Nicotinamide Riboside Improves Mitochondrial Health in Werner Syndrome: Preclinical Findings


Synopsis

Werner syndrome (WS) is a rare accelerated aging disease caused by mutations in the WRN gene, leading to metabolic problems and premature cell aging. This study found that loss of WRN increases senescence in stem cells and disrupts mitochondrial metabolism. Supplementing with nicotinamide riboside (NR) boosted NAD+ levels, reduced cell aging, and improved mitochondrial function in WRN-deficient stem cells and patient fibroblasts. WS cells also had lower mitochondrial NAD+ and changes in enzymes involved in NAD+ production. However, restoring NAD+ alone was not enough to fully restore cell proliferation, showing that WRN itself is essential for cell growth. These findings highlight NR's potential to improve mitochondrial health in WS, but WRN function remains critical, and further studies are needed.

Journal

Aging (Albany NY)

Read more

Alzheimer's Disease

Nicotinamide Riboside Restores Mitochondrial Function in Alzheimer's Disease: Preclinical Findings

Synopsis Mutant APP and amyloid-β (Aβ) disrupt mitochondrial dynamics and damage synapses in Alzheimer’s disease (AD), partly due to impaired mitophagy, the removal of dysfunctional mitochondria. ...

Read more
Cardiovascular Disease

The Effects of Boosting NAD+ on Atherosclerosis and Inflammation: Preclinical Findings

SynopsisNAD+ is a key molecule that activates sirtuins, which are linked to benefits like lifespan extension and improved metabolism in mice. Supplements like nicotinamide riboside (NR) are used to...

Read more